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This study investigates spatial and nonspatial working memory, anxiety related behavior, and motor activities in cadmium and/or
nicotine exposed female adolescent mice. P28 female adolescent mice (albino strain) were divided into four groups of five (𝑛 = 5)
mice each. A set of mice (Nic) received subcutaneous nicotine (2.0mg/kg) while a separate set (Cd) was treated with 2.0mg/kg
cadmium (subcutaneous). For the combined treatments of cadmium and nicotine, we administered 2.0mg/kg Nicotine and
2.0mg/kg of Cd. Subsequently, a separate group of animals (𝑛 = 5; control) received normal saline. The total duration of treatment
for all groupswas 28 days (P28–P56). At P56, the treatmentwas discontinued, afterwhich the animals were examined in behavioural
tests. Nicotine and cadmium increased the metabolism and food intake in the female adolescent mice. This also corresponded to
an increase in weight when compared with the control. However, a combined nicotine-cadmium treatment induced a decline in
weight of the animals versus the control. Also, nicotine administration increased the motor function, while cadmium and nicotine-
cadmium treatment caused a decline inmotor activity. Both nicotine and cadmium induced a reduction inmemory index; however,
nicotine-cadmium treatment induced the most significant decrease in nonspatial working memory.
1. Introduction
Nicotine, a cholinomimetic alkaloid, plays an important role
in the neurophysiologic changes which lead to dependence
[1, 2]. Nicotine is the main active ingredient in tobacco
smoke that causes andmaintains tobacco addiction [3].Many
studies have revealed that nicotine produces tolerance and
leads to psychological and physical dependences in adults [4].
Nicotine has been reported to increase 5-hydroxytryptamine
(serotonin, 5-HT) release in the cortex, striatum, hip-
pocampus, dorsal raphe nucleus (DRN), hypothalamus, and
spinal cord [5–7]. Also nicotine induces the release of sev-
eral other neurotransmitters, including acetylcholine (ACh),
noradrenaline, GABA, and glutamate [4, 8–11]. Although
the mechanism of nicotine-related tobacco smoke addiction
is unclear, it is suspected to involve several chemical path-
ways, neurotransmitter, and anatomical changes in different
brain areas [4, 12, 13].
The most predominant method of nicotine use is the
inhalation of tobacco smoke which consists of nicotine,
cadmium, and other alkaloids [14, 15]. Interestingly, studies
have shown that the effect of nicotine administered alone,
on behavior, differs from the observed behavioral changes
when it was coadministered with cadmium in tobacco smoke
[16, 17]. On its own, cadmium is a long-standing heavy metal
present in the tobacco leaf and the environment, with an aver-
age concentration of 0.1 and 0.5 parts per million (ppm) [18].
Following prolonged exposure, coupled with its ubiquitous
nature, bioaccumulation and toxicity of cadmium increased
in the body of smokers [18, 19]. In addition, exposure
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through inhalation or ingestion of agroproducts (phosphate
fertilizers) often amounts to the accumulation of cadmiumup
to a concentration of 300mg/kg [18, 20, 21].
In smokers, serum level of cadmium and nicotine is
usually higher than that observed in nonsmokers [22, 23].
With both having differential signaling pathways, neurotox-
icity is a common action of nicotine, cadmium, and their
metabolites. Although nicotine and nicotinic receptors are
naturally existing modulators in the central nervous system,
use of nicotine from tobacco smoke often increases the
concentration of nicotine in the blood and brain tissue
causing the observed toxicity [24, 25]. In effect, several
neurotransmitters (dopamine, 5HT, acetylcholine, GABA,
glutamate, and epinephrine) are upregulated [26, 27], while
signaling molecules like prolactin are suspected to be dereg-
ulated [28]. Consequently, this translates into behavioral
changes and addiction in the animals. As a result of inhalation
of nicotine in tobacco smoke, the presence of cadmium
in the smoke plays an important role in the behavioral
changes observed in prolonged use and addiction [27, 29]. In
addition, studies have shown that anatomical modifications
and degenerative changes occur in specific brain regions
after prolonged tobacco smoke addiction [30]. This has been
attributed to the persistent excitotoxicity of cholinergic recep-
tors through nicotine potentiation and cadmium-mediated
reactive oxygen species (ROS) production (cadmium inhibits
cytochrome a3 and cytochrome C oxidase) [29, 30].
It is evident, from previous findings, that 60% of smok-
ers start before the age of 14 (adolescent) and 90% show
dependence before the onset of adult hood [31]. In addition,
females have shown more sensitivity to nicotine use than
males and are described as being more vulnerable to nicotine
reward than males [31, 32]. Despite the striking evidence of
the involvement of tobacco smoke on behavior and addiction
in adolescent female, the exact interaction between nicotine
and cadmium in addiction and toxicity is yet to be elucidated.
Using behavioral tests, we have studied the effect of nicotine
and/or cadmium on weight, motor activity, and memory
function in female adolescent mice to demonstrate the role of
cadmium in the observed nicotine susceptibility and weight
loss seen in adolescent female mice.
2. Materials and Methods
2.1. Drugs. Nicotine bitartrate was generously given by Dr.
Maria A. Deluca of Department of Biological Science, Uni-
versity of Cagliari, Cagliari, Italy, and cadmium chloride
was obtained from Department of Chemical Sciences, Afe
Babalola University, Nigeria. The salts were dissolved in
saline (Drugfield Pharmaceutical LTD,Nigeria) and doses are
expressed as free base.
2.2. Animal Preparations and Treatment. 𝑁 = 20 female ado-
lescent mice (P28) were procured form the animals holding
facility of Afe Babalola University. The animals were kept
under standard laboratory conditions of 12-hour alternating
light and dark, controlled temperature, and adequate ventila-
tion.They were fed on standard rat chow containing proteins,
carbohydrate, fats, vitamins, minerals, and water ad libitum.
The animals weigh between 9 and 12 gm and were separated
randomly into four (4) groups of 𝑛 = 5 animals each.Nicotine
(Nc) was administered subcutaneously (2mg/Kg) to a set of
𝑛 = 5 animals, while a separate group received cadmium (Cd;
Subcutaneous) at a dose of 2mg/Kg [33, 34]. A combined
treatment group was set up and was treated with cadmium
(2mg/Kg) and nicotine (2mg/Kg) (Nc + Cd), while the
control (vehicle) received normal saline for the period of
the treatment (28 days; chronic administration).The nicotine
and/or cadmium were administered between 9 and 10 am
on each day of the treatment from P28 to P56. All protocols
were approved by Afe Babalola University Animal Care
Committee following the IACUC guidelines for animals use
in research and education.
2.3. Weight Measurements. The weight of the animals was
measured daily for the duration of the experiment. Also, the
daily food intake was measured using metabolic specially
designed metabolic cages.
2.4. Behavioral Assays. The behavioral tests were carried out
in a closed area with proper illumination and sound control.
All behavioral test performance was captured using a digital
video recorder and analyzed in Any-Maze software. The
animals were trained in the testing area 3 days to the actual
test and were allowed to acclimatize to the equipment used
for the various tests.
2.5. Rotarod Test. The animals were placed on a rotarod to
determine the latency of fall for three separate trials (T
1
, T
2
,
and T
3
) during which the speed of the rotarod was gradually
increased from 4 rpm to 35 rpm. The maximum duration
allowed for each trial was 3 minutes.
2.6. Novel Object Recognition Test (NOR). This was done to
evaluate the nonspatial working memory of the animals. For
the first trial (T
1
) animals were placed in a white opaque
test area with two identical objects for 5 minutes following
which an intertrial time (IT) of 60 minutes was observed. A
second trial (T
2
) was administered during which one of the
old objects was replaced with a novel object for 5 minutes
in the same test area. The performance of the animals was
recorded and analyzed to determine the exploration time on
old and new objects in T
2
, respectively. Subsequent analysis
involves the plotting of the memory index using the method
of Kruk-Słomka et al. [35].
2.7. Y-Maze. This was done to check the spatial working
memory of the animals. The rats were placed facing the edge
and allowed making their arm decision for total test duration
of 4 minutes. The frequencies of alteration between the arms
were recorded as plotted to determine the memory index
(percentage alteration).
2.8. Elevated Plus Maze (EPM). Using an elevated plus maze,
anxiety linked behaviors were assessed in the animals (𝑛 =
5 per group). These include the frequency of head dipping
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(HD), open arm duration (OAD), closed arm duration
(CAD), closed arm entries (CAE), and open arm entries
(OAE). The duration of the test was 4 minutes per mice.
3. Statistical Analyses
The recorded video performance was analyzed using Any-
Maze software to determine object exploration time (NOR),
percentage arm alteration (Y-maze), and latency of fall
(rotarod). Open and closed arm parameters were measured
for elevated plus maze. The data was plotted in one-way
ANOVA (GraphPad Prism Version 6.0) with Bonferroni
post-hoc test. Significance was set at ∗𝑃 < 0.05 and results
were expressed asmeans± standard error of themean (SEM).
Spearman’s correlationwas used to analyze the averageweight
gained per day and average food intake per day from P28 to
P56.
4. Results
4.1. Weight Changes. In order to evaluate the effect of nico-
tine, cadmium, or a combined treatment on the development
of the adolescent female rats, we measured the weight,
daily, for the duration of the experiment. Consequently, we
observed a significant increase in weight of the animals in the
cadmium, nicotine, and Nc + Cd group when compared with
the control (𝑃 < 0.05). Progression correlation shows that the
cadmium and nicotine treated groups recorded the highest
increase in weight from P28 to P56 while the combined
treatment with nicotine-cadmium recorded a decline from
P46 to P56 when compared with the control (Figure 1).
4.2. Daily Food Intake. To elucidate the effect of nicotine
and/or cadmium on metabolism (calorie intake) during the
adolescent stage of female development, the daily food
intake of each group was recorded for the duration of the
experiment. Similar to our observations on weight changes,
the nicotine treated animals recorded the most significant
increase in food intake rate when compared with the control
(𝑃 < 0.01∗∗). Interestingly, the cadmium treated animals
recorded an increase in food intake (𝑃 < 0.05∗) but was
less significant versus the nicotine treated group. In addi-
tion, cotreatment with nicotine-cadmium recorded a steady
decline in food intake around P30–P56. This also correlated
with the decline in weight observed in this group versus the
control around P46 (Figure 2).
4.3. Memory Function
4.3.1. Y-Maze. This was used to analyze the spatial working
memory in the female adolescent mice after an exposure
to nicotine, cadmium, or a combination of both (nicotine-
cadmium) during the adolescence period (P28–P56). We
evaluated the percentage alteration between the arms A, B,
and C and plotted the memory index (MI). No significant
change in spatial memory function was observed when the
treated groups were compared with the control (Figure 3).
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Figure 1: Spearman’s correlation showing the time-dependent
weight changes in the treatment groups and control. The nicotine
and/or cadmium treatment caused a significant increase in average
weight from P28 to P56 when compared with the control. It was
observed that nicotine-cadmium treatment induced a decline in
weight around P37 versus saline administeredmice statistically.This
is suggestive that the weight loss associated with tobacco use is not
an exclusive effect of nicotine, but an effect of combined nicotine
and cadmium in tobacco smoke.
4.3.2. NOR. The exploration time on old and new objects
was determined and used in calculating the memory index.
Although no statistically significant decline in memory
index was observed in the nicotine treated group, empirical
quantification shows a reduction in memory index versus
the control. Furthermore, the cadmium treatment and the
combined treatment group showed a decline in memory
function (𝑃 < 0.01) (Figure 4).
4.3.3. Rotarod. The latency of fall (LOF) was evaluated for
𝑛 = 5 animals in each group. Three (3) trails T
1
, T
2
, and T
3
were conducted for each animal for duration of 3 minutes
per trial. An intertrial time (IT) of 12 minutes was also
observed between the consecutive tests. The average time
spent on the rotarod for the three trials was determined as the
representative value for each animal. A significant increase in
LOF was observed in the nicotine treated group (𝑃 < 0.05)
when compared with the control. However, cadmium and
nicotine-cadmium treatment caused a significant decrease in
motor function, recording a decrease in LOFwhen compared
with the control (𝑃 < 0.01) and the nicotine treatment group
(𝑃 < 0.001). Similar to our findings in memory function, a
combination of nicotine and cadmium induced a decline in
motor function significantly when compared with nicotine
(𝑃 < 0.001) and cadmium (𝑃 < 0.05) (Figure 5).
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Figure 2: Average daily food intake (P28 to P56) in female
adolescent mice. Similar to the observations in weight changes, the
average daily food intake increased in the nicotine and cadmium
treated groups when compared with the control. Consequent of
nicotine-cadmium treatment, a decline in food intake was observed
around P46 versus the saline treated mice. This precedes the weight
loss in this group (P50) as shown in Figure 1. Each point represents
daily recorded food intake/group expressed as mean ± SEM.
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Figure 3: Percentage arm alteration expressed as memory index in
Y-maze. No statistical significance was observed in spatial memory
function for the treatment groups when compared with the control.
Empirically, slight increase was seen in all treatments with the
highest recorded in the combined nicotine-cadmium treatment.
4.3.4. Elevated Plus Maze (EPM). We employed the behav-
ioral assay technique to detect anxiety related behaviors in
the female adolescent mice after nicotine and/or cadmium
treatment.There was a statistical significance in the open and
closed arm distance for the treatment groups when compared
with the control (𝑃 < 0.05) (↑anxiety). The nicotine (Nc)
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Figure 4: Novel object recognition memory index. A significant
decline in memory index was observed in the cadmium and
combined (nicotine-cadmium) treatment groups (𝑃 < 0.05) when
compared with the control. Although nicotine treatment recorded
no statistically significant decline in memory index, empirical
quantification shows a decline in the memory index versus the
control. However, comparing the nicotine treated group with the
combined treatment group demonstrates the effect of cadmium in
facilitating decline in memory function when coadministered with
nicotine, similar to what is observed in tobacco smoke (statistical
significance: ∗𝑃 < 0.05).
and cadmium (Cd) treated groups recorded a significant
increase in closed arm distance (↑anxiety) versus the open
arm distance for the same group and the control (OA and CA
distance) (Figures 6(a) and 6(b)). The combined treatment
(nicotine-cadmium) showed a reduction in exploration dis-
tance for both open and closed arms (Figure 6(b)); however,
it also recorded a more significant closed arm distance versus
the open arm distance (↑↑anxiety; 𝑃 < 0.01). We next
analyzed the duration spent by each group in either the
open or closed arms to further determine the magnitude of
anxiety. Similar to our findings in the arm distance analysis,
the treatment groups recorded significantly higher durations
in the closed arm versus the open arm (↑anxiety) when
compared with the control (𝑃 < 0.05). Similarly, the most
significant increase in CAD was observed in the nicotine-
cadmium treatment (↑↑anxiety) (Figure 6(c)). Analysis of
the frequency of open and closed arm entries further sup-
ports these findings as the combined treatment (nicotine-
cadmium) showed more anxiety with the least rate of total
arm entries (decreased exploration) (Figure 6(d)).
5. Discussion
Taken together our findings suggest that nicotine or cadmium
treatment induced an increase in food consumption rate in
the female adolescent mice. In addition, a steady increase in
weight was observed in these groupswhen comparedwith the
control. However, the nicotine-cadmium treatment showed
a decline in food consumption rate and weight from P37
to P56, suggesting the negative effect of this combination
on metabolism and development. Furthermore we observed
that nicotine increased motor function in the mice when
Behavioural Neurology 5
Vehicle Nic Cd Nic + Cd
0
10
20
30
40
50
La
te
nc
y 
of
 fa
ll
∗∗
∗∗∗
∗∗
Figure 5: Latency of fall (LOF) in rotarod test for motor function.
Treatment with nicotine increased the latency of fall significantly
(↑motor function) when compared with the control group (𝑃 <
0.05). This is attributed to the role of nicotine in stimulating
cholinergic receptors at neuromuscular junctions and increasing
epinephrine release. The cadmium (𝑃 < 0.01) and nicotine-
cadmium (𝑃 < 0.001) treated groups showed a significant decrease
in motor function (↓LOF) when compared with the control and
nicotine treated group (𝑃 < 0.001). Subsequent analysis shows that
nicotine-cadmium treatment reduced motor function significantly
when compared with nicotine (𝑃 < 0.001) and cadmium (𝑃 < 0.05)
treatment groups, respectively (statistical significance: ∗𝑃 < 0.05,
∗∗
𝑃 < 0.01, and ∗∗∗𝑃 < 0.001).
compared with the control while cadmium induced a decline
in motor function. However, coadministration of nicotine-
cadmium induced the most significant decline in motor
function versus the control.We have also shown that nicotine
administered between P28 and P56 caused no significant
decline in memory function for spatial (Y-maze) and non-
spatial (NOR) memory while cadmium induced a decline in
memory function. Similar to our observations inmotor func-
tion, a combination of nicotine-cadmium treatment induced
themost significant decline inmemory function; especially in
novel object recognition memory. Taken together we deduce
that nicotine, when singly administered, holds the potential
of reducing memory function after prolonged use. However,
its combination with cadmium induces a significant decline
in memory function over a short period of time. Similarly,
cadmium administration induced a more significant decline
in nonspatial working memory when compared with the
nicotine-cadmium and control.
Anxiety linked behaviors were also observed both in the
nicotine and treatment groups (Figure 6(b)). In EPM, the
nicotine and cadmium treatment groups explored the closed
arm of the maze more than the open arm (𝑃 < 0.05) when
compared with the control. However a combined treatment
of nicotine and cadmium caused a decrease in exploration
distance in the closed arm of the maze. This also corre-
sponded to an increase in closed armduration, thus depicting
anxiety in this treatment group (reduced exploration dis-
tance and prolonged closed arm duration) (Figures 6(a)–
6(c)). The findings from EPM show that both nicotine
and cadmium can induce anxiety-linked behaviors after
prolonged use, a combined treatment of nicotine-cadmium,
similar to the tobacco smoke, caused a significant increase
in anxiety in the female adolescent mice. Other anxiety
linked symptoms observed in the combined treatment group
(nicotine-cadmium) include an increased food consumption,
decreased weight, and a decline in working memory.
Studies have shown that nicotine, a cholinergic agonist,
is capable of altering the rate of food consumption and
energy expenditure, thus leading to weight changes [36,
37]. Although the exact mechanism remains elusive, both
central and peripheral mechanisms are suspected to be
involved. The significant effect of nicotine on metabolism
has been described to occur through its ability to potentiate
several cholinergic receptors in the central nervous system
(hypothalamus) and peripheral nervous system [37, 38]. Our
findings suggest that nicotine treatment during the adoles-
cence period increased basal metabolism (food intake) and
the weight of the animals through nicotine mediated reward
system that affected brain energymetabolism regulation [38].
Although nicotine is themajor addictive substance in tobacco
smoke, our results show that cadmium participates in the
change in caloric intake that affect weight and energy expen-
diture (Figures 1 and 2). Our findings show that nicotine
use increased the body weight and calorie intake in female
adolescent mice; contrary to the idea that nicotine in tobacco
is responsible for the weight loss seen in smokers [39, 40]. In
addition, our results prove that a combination of nicotine and
cadmium might be responsible for the weight loss associated
with tobacco smoke as shown in Figures 1 and 2 (nicotine-
cadmium treatment). Thus we deduce from these findings
that changes observed in tobacco smoke are not exclusively
nicotinic but a combination of cholinergic-signaling and
other associated cellular mechanisms involving cadmium.
An increase in metabolism induced by nicotine is often
associated with an increased motor function [41]. A model
that addresses such function is linked with the ability of
nicotine to stimulate nicotine receptors at the neuromuscular
junctions and increase the release of epinephrine [42, 43].
As a result, glucose uptake increases in the muscles, thereby
facilitating an increase in motor function [44]. Although
this feature of nicotine use has been explored in Parkinson’s
disease (PD) therapeutics, it is often associatedwith increased
anxiety due to the central effect of epinephrine [45]. Similarly,
other studies have reported that smokers show a late onset
of motor dysfunctions in PD when compared to nonsmokers
due to the ability of nicotine to modify dopaminergic (D
1
)
receptor dynamics following degeneration of dopaminergic
neurons in the striatum [46–48]. However, this effect is
not exclusive to the effect of nicotine on motor function.
Recent findings suggest that nicotinemodulates intrasynaptic
dopaminergic release as part of its reward system. In addition,
theD
1
receptors observed in the striatumare also upregulated
in the reward related brain regions [49].
Although nicotine increased motor function, subsequent
analysis of animals treated with both nicotine-cadmium
and cadmium showed a decline in motor functions when
compared with the control and the nicotine group (Figure 4).
The role of cadmium in inhibition of tissue respiration
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Figure 6: (a, b) The average distance travelled in meters in elevated plus maze. (a) The open arm distance (checked bars) and closed arm
distance (plain bars) for the treatment groups were compared versus the control. Nicotine treated female mice showed a significance in the
distance covered in the open arm when compared with the control (𝑃 < 0.05). In furtherance, cadmium treated mice recorded a decrease in
total exploration distance when compared with the nicotine treated group (𝑃 < 0.05). Anxiety linked behaviors were observed in the nicotine
treatment as they explored the closed arm more than the open arm. Also, the cadmium and nicotine-cadmium treated groups showed a
significant decline in exploration time and explored the closed arm more than the open arm (statistical significance: ∗𝑃 < 0.05). (b) Track
plots of the mice during the 4 minutes exploration in EPM using Any-Maze software to demonstrate the open and closed arm distances. (c
and d) Elevated plus maze open/closed arm entries and duration. (c) Close arm (CAD::stripes) and open arm (OAD::plain) durations for
the treatment groups versus the control. Increased CAD was observed in the nicotine, cadmium, and nicotine-cadmium treatment group
(𝑃 < 0.05), thus depicting increased anxiety in these animals. (d) Bar chart showing the frequency of close arm (CAE) and open arm (OAE)
entries for the treatment groups and control. A significant difference (𝑃 < 0.05) was observed between the CAE and OAE in the nicotine and
cadmium treated groups (∗𝑃 < 0.05). No significance was seen when the OAE and CAE were compared for the combined nicotine-cadmium
treatment group (statistical significance: ∗𝑃 < 0.05).
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is suspected to be involved in the inhibition of synaptic
function and transmission, thus blocking nicotinic synaptic
effects in prolonged tobacco use (Figure 4). Similarly, Bier-
bower and Cooper demonstrated that carbon dioxide (CO
2
)
produced via inhibition of tissue respiration blocks auto-
nomic responses and inhibits glutamate neurotransmission
at the neuromuscular junctions. Other studies have shown
that cadmium is involved in the blockade of synaptic inputs
at neuromuscular junctions and the central nervous system
via upregulation of inhibitory neurotransmitter (GABA) and
cellular carbon dioxide, thus accounting for its effect in
reducing motor function when coadministered with nicotine
or solely [50, 51].
Primary targets for the central effect of nicotine are
receptors involved in the reward system and memory [52–
54]. Similar to our findings, other experiments involving the
post natal exposure of mice to nicotine between P28 and
P43 have shown that gender variations exist in the observed
memory functions and anxiety linked behaviors. While no
significant change was observed in males, female animals
showed an increased sensitivity to nicotine induced memory
loss and anxiety [55]. Similarly, cadmium induced toxicity
is capable of facilitating synaptic blockade and oxidative
stress which mediates degenerative changes and memory
loss. However, the effects of both nicotine and cadmium
in adolescent have been linked with memory loss during
use and after withdrawal [56]. Other documented evidence
of tobacco-mediated memory loss includes depletion of
nicotinic receptors in the prefrontal cortex [57, 58], increase
in number of immature hippocampal neurons [59, 60], and
inhibition of synaptic transmission both in the prefrontal
cortex and hippocampus [59, 61].
5.1. PublicHealth Significance. Social or societal stress is often
associated with adolescent humans who often engage in the
abuse of nicotine, cannabinoids, amphetamine, and alcohol
[62, 63]. Other reports have shown that tobacco use is most
prevalent among adolescents and young adults between the
ages of 13 and 25 years; furthermore, most start to smoke
between the ages of 12 and 14 years [64, 65]. Although no
significant difference was observed between the male and
female adolescent smoking rates [66], females, however, show
more susceptibility to nicotine-tobacco reward and addiction
[31]. The long-term effect of tobacco use in adolescent
females includes addiction [31, 66], sexual development [28],
attention and memory deficits [67], and dependence during
pregnancy [68].
6. Conclusion
We conclude that nicotine and cadmium when adminis-
tered separately induced an increase in metabolism, food
intake, and weight in adolescent female mice. However, the
decrease in weight associated with tobacco smoke is as a
result of nicotine-cadmium synergy rather than just nicotine.
Also, nicotine increased motor function while cadmium and
a combination of cadmium and nicotine decreased motor
function due to synaptic inhibition by cadmium. Nico-
tine, cadmium, and nicotine-cadmium treatment decreased
memory function, induced synaptic blockade, and possibly
downregulated nicotinic receptors in the prefrontal cortex
and hippocampus.
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